Analysis of altered level of blood-based biomarkers in prognosis of COVID-19 patients.

PloS one(2023)

引用 0|浏览1
暂无评分
摘要
Assessing and monitoring the elevated levels of glucose, urea, ALT, AST, ALP, WBC, CRP, PCT, IL-6, ferritin, LDH, D-Dimer, and CPK-MB and the lowered levels of total protein, albumin, and platelet could provide a basis for evaluation of improved prognosis and effective treatment in patients with COVID-19.
更多
查看译文
关键词
biomarkers,prognosis,blood-based
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要